Investor lawsuit against NY hemp biotech company tossed
Industrial Hemp NewsMarijuana Laws, Regulations, & Politics January 20, 2021 MJ Shareholders 0
A federal judge in New York has dismissed an investor’s lawsuit accusing a hemp biotech company of lying to promote its stock price.
Based in Williamsville, 22nd Century Group researches the genetics of tobacco and cannabis plants and was accused of trying to manipulate its stock price through misrepresenting its business. Plaintiffs were seeking class-action status.
Judge John Sinatra Jr. dismissed the case last week, saying the company had no duty to disclose that it had paid for promotional articles.
22nd Century Group CEO James A. Mish applauded the dismissal and said in a statement the claim was “baseless.”
22nd Century Group trades on the NYSE American exchange as XXII.
Law 360 first reported the lawsuit’s dismissal.
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.